The ASC VBP Report to Congress was authorized under Section 3006(f) of the Patient Protection and Affordable Care Act (Pub. CMS views VBP as an important step forward in revamping how Medicare pays for health care services moving the program towards rewarding better value, outcomes, and innovations, instead of merely volume. In addition, it considers the steps required in designing and implementing an ASC VBP program for payments under the Medicare program. The Report to Congress (PDF)describes the current efforts to improve quality and payment efficiency in ASCs. The Secretary submits a report to Congress containing this plan. The Affordable Care Act requires the Secretary of Health and Human Services to develop a plan to implement a value-based purchasing (VBP) program for payments under the Medicare program for ambulatory surgical centers (ASCs). Value Based Purchasing Program for Ambulatory Surgical Centers The CY2022 OPPS/ASC Notice of Proposed Rulemaking (NPRM) (CMS-1753-P) including related links to the CY2022 NPRM ASC Payment Rate addenda and wage index files are now available. Beginning with the January 2015 ASC payment system quarterly update change request, the list of drugs and biologicals with corrected payments rates, for a particular quarter, are accessible from the left menu link titled “Restated Drug and Biological Payment Rates”.

These retroactive corrections typically occur on a quarterly basis as a part of the ASC payment system quarterly update change request. Some drugs and biologicals based on ASP methodology may have payment rates that are corrected retroactively. ASC Drugs and Biologicals with Quarterly Restated Payment Rates

Medicare 2019 asc approved procedures